T. Doğruel Et Al. , "Purvalanol and roscovitine exert their apoptotic effect differently in terms of mTOR downstream signalling route," 3rd AntiCancer Agent Development Congress , Turkey, 2015
Doğruel, T. Et Al. 2015. Purvalanol and roscovitine exert their apoptotic effect differently in terms of mTOR downstream signalling route. 3rd AntiCancer Agent Development Congress , (Turkey).
Doğruel, T., RENCÜZOĞULLARI, Ö., ARISAN, E. D., OBAKAN YERLİKAYA, P., ÇOKER GÜRKAN, A., & ÜNSAL, Z. N., (2015). Purvalanol and roscovitine exert their apoptotic effect differently in terms of mTOR downstream signalling route . 3rd AntiCancer Agent Development Congress, Turkey
Doğruel, Tuğçe Et Al. "Purvalanol and roscovitine exert their apoptotic effect differently in terms of mTOR downstream signalling route," 3rd AntiCancer Agent Development Congress, Turkey, 2015
Doğruel, Tuğçe Et Al. "Purvalanol and roscovitine exert their apoptotic effect differently in terms of mTOR downstream signalling route." 3rd AntiCancer Agent Development Congress , Turkey, 2015
Doğruel, T. Et Al. (2015) . "Purvalanol and roscovitine exert their apoptotic effect differently in terms of mTOR downstream signalling route." 3rd AntiCancer Agent Development Congress , Turkey.
@conferencepaper{conferencepaper, author={Tuğçe Doğruel Et Al. }, title={Purvalanol and roscovitine exert their apoptotic effect differently in terms of mTOR downstream signalling route}, congress name={3rd AntiCancer Agent Development Congress}, city={}, country={Turkey}, year={2015}}